Positive feedback of the amphiregulin-EGFR-ERK pathway mediates PM2.5 from wood smoke-induced MUC5AC expression in epithelial cells.

Homo sapiensRattus norvegicus fine respirable suspended particulate matter

Study subjects

SUBJECT:huang-rat-woodsmoke

Female Sprague-Dawley rat, wood smoke inhalation model

type: InVivoSubject Rattus norvegicus NCBITaxon:10116 sex: female age: 9 week

Healthy animals; readouts taken from 4 um para-sagittal sections of the right lung and from whole-lung RNA, n = 5 rats per group

soma:huang-primary-ali-001

Primary human bronchial/tracheal epithelial ALI culture

type: CellularSystem Homo sapiens NCBITaxon:9606 bronchial epithelial cell CL:0002328
soma:huang-h292-001

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-002

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-003

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-004

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-005

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-006

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082
soma:huang-h292-007

NCI-H292 human airway epithelial cell line

type: CellularSystem Homo sapiens NCBITaxon:9606 epithelial cell of lung CL:0000082

Goblet cell assays

GCM:huang-woodsmoke-rat-3mo

Airway mucous cell metaplasia and mucin expression in rats after 3 months of wood smoke

AB-PAS staining, MUC5AC/MUC5B immunohistochemistry and whole-lung real-time PCR in Sprague-Dawley rats exposed to wood smoke or clean air for three months (n = 5 rats/group). Wood smoke induced severe airway mucous cell metaplasia and highly elevated MUC5AC; MUC5B also rose but not significantly. Quantification is reported only in figure panels, so no numeric values are recorded here.

Exposure conditions

ConditionAgentConcentrationDuration
Clean room air for 3 months (control group)
EXPOSURE:huang-rat-air-3mo
— — 3 month
Wood smoke, 1 h four times daily, five days per week, for 3 months (exposure-room average PM2.5 20.4 mg/m3, CO 90.15 ppm)
EXPOSURE:huang-rat-woodsmoke-3mo
— — 3 month

Outputs

GroupOutputDescription
control Clean-air control rat airway
GCM:huang-woodsmoke-rat-3mo-output-control · under EXPOSURE:huang-rat-air-3mo
Control animals did not exhibit mucous cell metaplasia; MUC5AC and MUC5B staining and whole-lung transcript levels served as the reference for the wood smoke group.
treated Wood smoke-exposed rat airway
GCM:huang-woodsmoke-rat-3mo-output-woodsmoke · under EXPOSURE:huang-rat-woodsmoke-3mo
Severe airway mucous cell metaplasia with highly elevated MUC5AC by immunochemistry and real-time PCR; MUC5B elevated but not statistically significant.

Evidence

exposure to wood smoke for 3 months induced severe airway mucous cell metaplasia, whereas the control animals did not exhibit mucous cell metaplasia
SUPPORT MODEL ORGANISM PMID:28894207

States the in vivo contrast this assay records: wood smoke produced severe airway mucous cell metaplasia while control animals did not.

Furthermore, both immunochemistry (Fig. 1C,D and H) and real-time PCR (Fig. 1J) revealed that MUC5AC levels were highly elevated in the wood smoke group.
SUPPORT MODEL ORGANISM PMID:28894207

Names the two readouts (immunochemistry and real-time PCR) behind the elevated MUC5AC recorded for the wood smoke output record.

MUC5B expression (Fig. 1E,F,I and J) was also elevated after wood smoke challenge, although this changes was not statistically significant.
SUPPORT MODEL ORGANISM PMID:28894207

Supports recording the MUC5B rise as non-significant rather than as an effect.

GCM:huang-wspm25-primary-ali-24h

MUC5AC mRNA and protein in primary human airway epithelial ALI cultures after 24 h WSPM2.5

Differentiated primary human bronchial/tracheal epithelial cells at air-liquid interface treated apically with WSPM2.5 (8 or 40 ug/ml) for 24 h. MUC5AC mRNA by real-time PCR and MUC5AC protein in culture supernatants by ELISA, both expressed as fold change over untreated cells; the control record anchors that scale at 1.0.

Exposure conditions

ConditionAgentConcentrationDuration
Clean-filter extract containing 0.1% DMSO, 24 hours (control)
EXPOSURE:huang-primary-vehicle-24h
— — 24 hour
WSPM2.5 8 ug/ml apically for 24 hours
EXPOSURE:huang-primary-wspm25-8ug-24h
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 24 hour
WSPM2.5 40 ug/ml (10 ug/cm2) apically for 24 hours
EXPOSURE:huang-primary-wspm25-40ug-24h
fine respirable suspended particulate matter
ENVO:01000415
40 microgram per milliliter 24 hour

Outputs

GroupOutputDescription
vehicle_control Untreated control MUC5AC in primary ALI cultures
GCM:huang-wspm25-primary-ali-24h-output-control · under EXPOSURE:huang-primary-vehicle-24h
Reference condition for the fold-change scale; the paper reports treated values as the relative change over untreated cells.
muc5ac mrna expression: 1.0 fold change (mean; n=3) muc5ac protein expression: 1.0 fold change (mean; n=3)
treated MUC5AC after 8 ug/ml WSPM2.5 in primary ALI cultures
GCM:huang-wspm25-primary-ali-24h-output-8ug · under EXPOSURE:huang-primary-wspm25-8ug-24h
muc5ac mrna expression: 2.44 fold change (mean; n=3) muc5ac protein expression: 1.64 fold change (mean; n=3)
treated MUC5AC after 40 ug/ml WSPM2.5 in primary ALI cultures
GCM:huang-wspm25-primary-ali-24h-output-40ug · under EXPOSURE:huang-primary-wspm25-40ug-24h
muc5ac mrna expression: 4.55 fold change (mean; n=3) muc5ac protein expression: 2.29 fold change (mean; n=3)

Evidence

MUC5AC mRNA expression increased 2.44- and 4.55-fold (Fig. 2A), whereas MUC5AC protein expression increased 1.64- and 2.29-fold in the presence of 8 and 40 μg/ml WSPM2.5, respectively
SUPPORT IN VITRO PMID:28894207

Gives the four fold-change values recorded in the 8 and 40 ug/ml output records for MUC5AC mRNA and protein.

WSPM2.5 could induce MUC5AC production in both primary human airway epithelial cells and the NCI-H292 cell line.
SUPPORT IN VITRO PMID:28894207

Confirms that the MUC5AC induction recorded here was seen in primary human airway epithelial cells, the study subject of this assay.

GCM:huang-wspm25-h292-24h

MUC5AC mRNA and protein in NCI-H292 cells after 24 h WSPM2.5

NCI-H292 cells treated with non-cytotoxic WSPM2.5 concentrations (0.5-24 ug/ml) for 24 h. At 8 ug/ml, MUC5AC mRNA rose 40.26-fold and MUC5AC protein in the supernatant 4.65-fold over untreated cells. Induction was also time dependent, rising continuously across the 36 h experiment. The control record anchors the fold-change scale at 1.0.

Exposure conditions

ConditionAgentConcentrationDuration
Clean-filter extract containing 0.1% DMSO, 24 hours (control)
EXPOSURE:huang-h292-vehicle-24h
— — 24 hour
WSPM2.5 8 ug/ml (2 ug/cm2) for 24 hours
EXPOSURE:huang-h292-wspm25-8ug-24h
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 24 hour

Outputs

GroupOutputDescription
vehicle_control Untreated control MUC5AC in NCI-H292 cells
GCM:huang-wspm25-h292-24h-output-control · under EXPOSURE:huang-h292-vehicle-24h
Reference condition for the fold-change scale; the paper states the fold increase is the relative change over untreated cells.
muc5ac mrna expression: 1.0 fold change (mean; n=5) muc5ac protein expression: 1.0 fold change (mean; n=6)
treated MUC5AC after 8 ug/ml WSPM2.5 in NCI-H292 cells
GCM:huang-wspm25-h292-24h-output-8ug · under EXPOSURE:huang-h292-wspm25-8ug-24h
muc5ac mrna expression: 40.26 fold change (mean; n=5) muc5ac protein expression: 4.65 fold change (mean; n=6)

Evidence

In the NCI-H292 epithelial cell line, WSPM2.5 dose dependently increased MUC5AC mRNA (Fig. 3A) and protein expression levels (Fig. 3C) (at 8 μg/ml, WSPM2.5 increased MUC5AC mRNA expression 40.26-fold and MUC5AC protein expression 4.65-fold).
SUPPORT IN VITRO PMID:28894207

Gives the two fold-change values recorded in the 8 ug/ml output record for MUC5AC mRNA and protein.

WSPM2.5 also induced MUC5AC production time-dependently [both MUC5AC mRNA (Fig. 3B) and MUC5AC protein levels (Fig. 3D) increased continuously throughout the 36-h experiment
SUPPORT IN VITRO PMID:28894207

Supports the time-dependence stated in this assay's description, which is reported only as figure panels.

EGFR signaling assays

EGFR:huang-wspm25-h292-phospho

EGFR and ERK phosphorylation in NCI-H292 cells after WSPM2.5

Western blot time course in NCI-H292 cells stimulated with WSPM2.5 8 ug/ml. EGFR phosphorylation rose continuously, first significant at 60 min. ERK phosphorylation was biphasic, starting within 5 min with a second wave from 8 h to 24 h. AG1478 abolished ERK activation, placing EGFR upstream of ERK. Densitometry is reported only in figure panels, so no numeric values are recorded.

normalization reference: GAPDH phosphorylation site: Tyr1068

Exposure conditions

ConditionAgentConcentrationDuration
Clean-filter extract containing 0.1% DMSO, unstimulated control
EXPOSURE:huang-h292-vehicle-phospho
— — —
WSPM2.5 8 ug/ml for 5 minutes
EXPOSURE:huang-h292-wspm25-8ug-5min
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 5 minute
WSPM2.5 8 ug/ml for 60 minutes
EXPOSURE:huang-h292-wspm25-8ug-60min
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 60 minute

Outputs

GroupOutputDescription
vehicle_control Unstimulated control p-EGFR and p-ERK
EGFR:huang-wspm25-h292-phospho-output-control · under EXPOSURE:huang-h292-vehicle-phospho
Untreated lane used as the densitometry reference for phospho-EGFR (normalized to GAPDH) and phospho-ERK (normalized to total ERK).
treated p-ERK 5 minutes after WSPM2.5
EGFR:huang-wspm25-h292-phospho-output-5min · under EXPOSURE:huang-h292-wspm25-8ug-5min
downstream kinase activation: ERK phosphorylation biphasic: first wave starting within 5 min, second wave starting at 8 h and lasting until 24 h; abolished by the EGFR inhibitor AG1478
treated p-EGFR 60 minutes after WSPM2.5
EGFR:huang-wspm25-h292-phospho-output-60min · under EXPOSURE:huang-h292-wspm25-8ug-60min
EGFR phosphorylation increased continuously after WSPM2.5, with the first significant increase observed at 60 min.

Evidence

EGFR phosphorylation increased continuously, and a significant increase began to be observed at 60 min (Fig. 4A and B). Pretreatment with AG1478, an EGFR-selective tyrosine kinase inhibitor, significantly prevented MUC5AC expression
SUPPORT IN VITRO PMID:28894207

States the EGFR phosphorylation time course and the AG1478 result recorded in the 60 min output record.

biphasic activation of ERK was observed, with phosphorylation starting within 5 min. The second wave started at 8 h and lasted until 24 h.
SUPPORT IN VITRO PMID:28894207

States the biphasic ERK activation recorded in the 5 min output record.

EGFR appears to function upstream of ERK, as AG1478 abolished ERK activation
SUPPORT IN VITRO PMID:28894207

Supports placing EGFR upstream of ERK, as this assay's description states.

EGFR:huang-ligand-dependence-h292

Ligand dependence of WSPM2.5-induced EGFR activation in NCI-H292 cells

NCI-H292 cells pretreated for 1 h with an EGFR-neutralizing antibody (0.5, 1 or 2 ug/ml), which prevents ligand binding to EGFR, or with a mouse control IgG, then stimulated with WSPM2.5 8 ug/ml. The antibody significantly reduced both EGFR phosphorylation (60 min) and MUC5AC expression (24 h), showing that EGFR activation by WSPM2.5 is ligand dependent. Results are reported as figure panels, so no numeric values are recorded.

normalization reference: GAPDH phosphorylation site: Tyr1068

Exposure conditions

ConditionAgentConcentrationDuration
WSPM2.5 8 ug/ml alone (no neutralizing antibody)
EXPOSURE:huang-h292-wspm25-alone
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter —
EGFR-neutralizing antibody 0.5-2 ug/ml for 1 h, then WSPM2.5 8 ug/ml
EXPOSURE:huang-h292-wspm25-anti-egfr
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter —

Outputs

GroupOutputDescription
treated WSPM2.5 alone
EGFR:huang-ligand-dependence-h292-output-wspm25 · under EXPOSURE:huang-h292-wspm25-alone
WSPM2.5 stimulation without neutralizing antibody; the reference arm for the antibody comparison.
treated WSPM2.5 with EGFR-neutralizing antibody
EGFR:huang-ligand-dependence-h292-output-anti-egfr · under EXPOSURE:huang-h292-wspm25-anti-egfr
EGFR-neutralizing antibody significantly reduced WSPM2.5-induced EGFR phosphorylation and MUC5AC expression.

Evidence

In addition, treatment with EGFR-neutralizing antibody, which prevents ligand binding to EGFR, significantly reduced EGFR phosphorylation (Fig. 4D and E) and MUC5AC expression (Fig. 4F), suggesting ligand-dependent EGFR activation in WSPM2.5-mediated MUC5AC expression.
SUPPORT IN VITRO PMID:28894207

States the neutralizing-antibody result and the ligand-dependent interpretation this assay records.

EGFR:huang-ligand-neutralization-h292

Identification of amphiregulin as the EGFR ligand driving WSPM2.5-induced signaling

NCI-H292 cells pretreated 1 h with neutralizing antibodies against AR, TGF-alpha or HB-EGF, then stimulated with WSPM2.5 (60 min for p-EGFR, 5 min for p-ERK, 24 h for MUC5AC mRNA). AR neutralization suppressed most of the WSPM2.5-induced EGFR and ERK phosphorylation and MUC5AC expression, while TGF-alpha and HB-EGF blockade gave only non-significant partial reductions. Recombinant AR (300-1,800 pg/ml) induced MUC5AC dose-dependently. Results are reported as figure panels, so no numeric values are recorded.

normalization reference: GAPDH

Exposure conditions

ConditionAgentConcentrationDuration
WSPM2.5 8 ug/ml with isotype-matched control IgG
EXPOSURE:huang-h292-wspm25-igg
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter —
Anti-AR neutralizing antibody for 1 h, then WSPM2.5 8 ug/ml
EXPOSURE:huang-h292-wspm25-anti-ar
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter —
Anti-TGF-alpha or anti-HB-EGF neutralizing antibody for 1 h, then WSPM2.5 8 ug/ml
EXPOSURE:huang-h292-wspm25-anti-tgfa-hbegf
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter —
Recombinant AR 300-1,800 pg/ml for 24 hours
EXPOSURE:huang-h292-recombinant-ar-24h
— — 24 hour

Outputs

GroupOutputDescription
control WSPM2.5 with control IgG
EGFR:huang-ligand-neutralization-h292-output-igg · under EXPOSURE:huang-h292-wspm25-igg
Isotype-matched control antibody arm; the reference for the neutralizing-antibody arms.
treated WSPM2.5 with AR-neutralizing antibody
EGFR:huang-ligand-neutralization-h292-output-anti-ar · under EXPOSURE:huang-h292-wspm25-anti-ar
AR neutralization suppressed most of the WSPM2.5-induced EGFR and ERK phosphorylation and MUC5AC gene expression.
treated WSPM2.5 with TGF-alpha- or HB-EGF-neutralizing antibody
EGFR:huang-ligand-neutralization-h292-output-anti-tgfa-hbegf · under EXPOSURE:huang-h292-wspm25-anti-tgfa-hbegf
Blockade of TGF-alpha or HB-EGF gave a partial reduction that failed to reach statistical significance.
treated Recombinant AR without WSPM2.5
EGFR:huang-ligand-neutralization-h292-output-recombinant-ar · under EXPOSURE:huang-h292-recombinant-ar-24h
Recombinant AR dose-dependently induced MUC5AC expression, confirming AR is sufficient for the response.

Evidence

Interestingly, AR neutralization suppressed most of the WSPM2.5-induced EGFR and ERK phosphorylation (Fig. 7A,B and C) and MUC5AC gene expression (Fig. 7D), whereas blockade of TGF-α or HB-EGF showed a partial reduction, but this decrease failed to reach statistical significance.
SUPPORT IN VITRO PMID:28894207

States the contrast between AR neutralization and TGF-alpha/HB-EGF blockade that the three treated output records here capture.

Furthermore, recombinant AR dose-dependently induced MUC5AC expression (Fig. 7E). Thus, AR is crucial in mediating the WSPM2.5-induced activation of the EGFR-ERK pathway and MUC5AC up-regulation.
SUPPORT IN VITRO PMID:28894207

Supports the recombinant-AR arm and the conclusion that AR drives EGFR-ERK activation and MUC5AC up-regulation.

Amphiregulin (AR) was identified as the major ligand responsible for EGFR-ERK signaling activation and MUC5AC expression.
SUPPORT IN VITRO PMID:28894207

The paper's own summary of the finding this assay records: AR is the major ligand responsible for EGFR-ERK activation and MUC5AC expression.

Gene expression assays

GEX:huang-ar-h292-timecourse

Amphiregulin mRNA and protein in NCI-H292 cells over 36 h of WSPM2.5

NCI-H292 cells exposed to WSPM2.5 8 ug/ml for 2-36 h. AR mRNA by real-time PCR was elevated at 2 h (2.91-fold) and significantly increased at 24 h; AR protein released into the medium (ELISA) was significantly higher at 24 and 36 h. The control record anchors the fold-change scale at 1.0; the 24 and 36 h protein values are reported only in figure panels.

target gene: AREG (amphiregulin, AR) gene expression method: real-time quantitative RT-PCR and ELISA normalization reference: GAPDH

Exposure conditions

ConditionAgentConcentrationDuration
Clean-filter extract containing 0.1% DMSO, untreated control
EXPOSURE:huang-h292-vehicle-ligand
— — —
WSPM2.5 8 ug/ml for 2 hours
EXPOSURE:huang-h292-wspm25-8ug-2h
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 2 hour
WSPM2.5 8 ug/ml for 36 hours
EXPOSURE:huang-h292-wspm25-8ug-36h
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 36 hour

Outputs

GroupOutputDescription
vehicle_control Untreated control AR mRNA
GEX:huang-ar-h292-timecourse-output-control · under EXPOSURE:huang-h292-vehicle-ligand
Reference condition for the fold-change scale.
mrna level: 1.0 fold change (mean; n=3)
treated AR mRNA 2 h after WSPM2.5
GEX:huang-ar-h292-timecourse-output-2h · under EXPOSURE:huang-h292-wspm25-8ug-2h
mrna level: 2.91 fold change (mean; n=3)
treated AR protein release at 24-36 h after WSPM2.5
GEX:huang-ar-h292-timecourse-output-36h · under EXPOSURE:huang-h292-wspm25-8ug-36h
AR protein levels in the culture medium were significantly higher at 24 and 36 h; the values themselves are reported only in figure panels.

Evidence

The time-course study of WSPM2.5 exposure revealed elevated AR mRNA levels at 2 h (2.91-fold), with a significant increase at 24 h.
SUPPORT IN VITRO PMID:28894207

Gives the 2.91-fold AR mRNA value recorded in the 2 h output record and the significant increase at 24 h.

Consistent with the increase in AR mRNA expression, the AR protein levels were significantly higher at 24 and 36 h.
SUPPORT IN VITRO PMID:28894207

Supports the AR protein result stated in this assay's description and recorded qualitatively in the 24-36 h output record.

GEX:huang-hbegf-h292-36h

HB-EGF mRNA in NCI-H292 cells after 36 h of WSPM2.5

HB-EGF mRNA was significantly higher after 36 h of WSPM2.5 8 ug/ml (3.38-fold), but HB-EGF protein release measured by ELISA remained unchanged. The control record anchors the fold-change scale at 1.0.

target gene: HBEGF (heparin-binding EGF-like growth factor) gene expression method: real-time quantitative RT-PCR normalization reference: GAPDH

Exposure conditions

ConditionAgentConcentrationDuration
Clean-filter extract containing 0.1% DMSO, untreated control
EXPOSURE:huang-h292-vehicle-hbegf
— — —
WSPM2.5 8 ug/ml for 36 hours
EXPOSURE:huang-h292-wspm25-8ug-36h-hbegf
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 36 hour

Outputs

GroupOutputDescription
vehicle_control Untreated control HB-EGF mRNA
GEX:huang-hbegf-h292-36h-output-control · under EXPOSURE:huang-h292-vehicle-hbegf
Reference condition for the fold-change scale.
mrna level: 1.0 fold change (mean; n=3)
treated HB-EGF mRNA 36 h after WSPM2.5
GEX:huang-hbegf-h292-36h-output-36h · under EXPOSURE:huang-h292-wspm25-8ug-36h-hbegf
mrna level: 3.38 fold change (mean; n=3)

Evidence

HB-EGF mRNA expression was significantly higher after 36 h of exposure (3.38-fold; Fig. 6A).
SUPPORT IN VITRO PMID:28894207

Gives the 3.38-fold HB-EGF mRNA value recorded in the 36 h output record.

GEX:huang-ar-autocrine-feedback-h292

EGFR-ERK dependence and de novo synthesis of amphiregulin in NCI-H292 cells

Pretreatment with EGFR-neutralizing antibody (0.5 ug/ml), AG1478 (10 uM) or PD98059 (5 uM) significantly reduced WSPM2.5-induced AR mRNA expression and AR release, and exogenous AR (1,800 pg/ml) increased AR mRNA in an AG1478- and PD98059-sensitive way. Actinomycin D and cycloheximide (10 ug/ml) inhibited AR secretion and attenuated MUC5AC mRNA, showing de novo AR synthesis is required. This closes the positive feedback loop between AR release and EGFR-ERK activation. Results are reported as figure panels, so no numeric values are recorded.

target gene: AREG (amphiregulin, AR) gene expression method: real-time quantitative RT-PCR and ELISA normalization reference: GAPDH

Exposure conditions

ConditionAgentConcentrationDuration
WSPM2.5 8 ug/ml for 24 hours (no inhibitor)
EXPOSURE:huang-h292-wspm25-24h-feedback
fine respirable suspended particulate matter
ENVO:01000415
8 microgram per milliliter 24 hour
AG1478 10 uM for 1 h, then WSPM2.5 8 ug/ml for 24 hours
EXPOSURE:huang-h292-wspm25-ag1478
— 10 micromolar 24 hour
PD98059 5 uM for 1 h, then WSPM2.5 8 ug/ml for 24 hours
EXPOSURE:huang-h292-wspm25-pd98059
— 5 micromolar 24 hour
Actinomycin D or cycloheximide 10 ug/ml, then WSPM2.5 8 ug/ml for 24 hours
EXPOSURE:huang-h292-wspm25-actd-chx
— — 24 hour

Outputs

GroupOutputDescription
treated WSPM2.5 alone
GEX:huang-ar-autocrine-feedback-h292-output-wspm25 · under EXPOSURE:huang-h292-wspm25-24h-feedback
WSPM2.5 stimulation without inhibitor; the reference arm for the inhibitor comparisons.
treated WSPM2.5 with the EGFR inhibitor AG1478
GEX:huang-ar-autocrine-feedback-h292-output-ag1478 · under EXPOSURE:huang-h292-wspm25-ag1478
AG1478 significantly reduced WSPM2.5-induced AR mRNA expression and AR release.
treated WSPM2.5 with the ERK kinase inhibitor PD98059
GEX:huang-ar-autocrine-feedback-h292-output-pd98059 · under EXPOSURE:huang-h292-wspm25-pd98059
PD98059 significantly reduced WSPM2.5-induced AR mRNA expression and AR release.
treated WSPM2.5 with actinomycin D or cycloheximide
GEX:huang-ar-autocrine-feedback-h292-output-actd-chx · under EXPOSURE:huang-h292-wspm25-actd-chx
Actinomycin D and cycloheximide inhibited AR secretion at baseline and upon WSPM2.5 stimulation, and attenuated MUC5AC mRNA expression.

Evidence

Pretreatment with anti-EGFR, AG1478 or PD98059 significantly reduced WSPM2.5-induced AR mRNA expression (Fig. 9A) and AR release (Fig. 9B), indicating that the autocrine effects of AR are mediated by the EGFR-ERK pathway in epithelial cells.
SUPPORT IN VITRO PMID:28894207

States the inhibitor result recorded in the EGFR-ERK-blocked output records: AR expression and release depend on the EGFR-ERK pathway.

ActD and CHX not only significantly inhibited AR secretion at baseline or upon WSPM2.5 stimulation (Fig. 8A and B) but also attenuated MUC5AC mRNA expression (Fig. 8C and D), indicating that de novo synthesis of AR is needed for the transcriptional regulation of MUC5AC.
SUPPORT IN VITRO PMID:28894207

Supports the ActD/CHX output record and the conclusion that de novo AR synthesis is needed for MUC5AC transcription.

In turn, EGFR-ERK pathway activation was found to contribute to the de novo synthesis of AR.
SUPPORT IN VITRO PMID:28894207

The paper's own summary of the feedback arm this assay records: EGFR-ERK activation contributes to de novo AR synthesis.

Response comparisons

COMP:huang-primary-muc5ac-mrna-8ug

Change in MUC5AC mRNA, 8 ug/ml WSPM2.5 vs untreated, primary ALI cultures

measurement: muc5ac_mrna_expression direction: increased type: fold change value: 2.44 fold change derivation: reported in paper from assay: GCM:huang-wspm25-primary-ali-24h
COMP:huang-primary-muc5ac-mrna-40ug

Change in MUC5AC mRNA, 40 ug/ml WSPM2.5 vs untreated, primary ALI cultures

measurement: muc5ac_mrna_expression direction: increased type: fold change value: 4.55 fold change derivation: reported in paper from assay: GCM:huang-wspm25-primary-ali-24h
COMP:huang-primary-muc5ac-protein-8ug

Change in MUC5AC protein, 8 ug/ml WSPM2.5 vs untreated, primary ALI cultures

measurement: muc5ac_protein_expression direction: increased type: fold change value: 1.64 fold change derivation: reported in paper from assay: GCM:huang-wspm25-primary-ali-24h
COMP:huang-primary-muc5ac-protein-40ug

Change in MUC5AC protein, 40 ug/ml WSPM2.5 vs untreated, primary ALI cultures

measurement: muc5ac_protein_expression direction: increased type: fold change value: 2.29 fold change derivation: reported in paper from assay: GCM:huang-wspm25-primary-ali-24h
COMP:huang-h292-muc5ac-mrna-8ug

Change in MUC5AC mRNA, 8 ug/ml WSPM2.5 vs untreated, NCI-H292 cells

measurement: muc5ac_mrna_expression direction: increased type: fold change value: 40.26 fold change derivation: reported in paper from assay: GCM:huang-wspm25-h292-24h
COMP:huang-h292-muc5ac-protein-8ug

Change in MUC5AC protein, 8 ug/ml WSPM2.5 vs untreated, NCI-H292 cells

measurement: muc5ac_protein_expression direction: increased type: fold change value: 4.65 fold change derivation: reported in paper from assay: GCM:huang-wspm25-h292-24h
COMP:huang-ar-mrna-2h

Change in AR mRNA, 2 h WSPM2.5 vs untreated, NCI-H292 cells

measurement: mrna_level direction: increased type: fold change value: 2.91 fold change derivation: reported in paper from assay: GEX:huang-ar-h292-timecourse
COMP:huang-hbegf-mrna-36h

Change in HB-EGF mRNA, 36 h WSPM2.5 vs untreated, NCI-H292 cells

measurement: mrna_level direction: increased type: fold change value: 3.38 fold change derivation: reported in paper from assay: GEX:huang-hbegf-h292-36h

Key-event relationships

KER:huang-egfr-to-mucin

EGFR activation leads to mucin hypersecretion

EGFR activation (activated) → directly leads to → Mucin hypersecretion (increased) strong support
Furthermore, pretreatment with the selective ERK kinase inhibitor PD98059 (Fig. 5C) significantly inhibited WSPM2.5-induced MUC5AC expression, indicating that WSPM2.5-induced MUC5AC production is dependent on ERK activation.
SUPPORT IN VITRO PMID:28894207

Inhibitor reversal: blocking ERK downstream of EGFR abolished the MUC5AC induction, which is the causal link this relationship asserts.

In summary, this study found that WSPM2.5 induces MUC5AC expression through the AR-EGFR-ERK pathway and that subsequent activation of EGFR-ERK leads to autocrine effects of AR, with the released AR further promoting its own expression.
SUPPORT IN VITRO PMID:28894207

The paper's own summary that WSPM2.5 induces MUC5AC expression through the AR-EGFR-ERK pathway.

Protocols

PROTOCOL:huang-woodsmoke-exposure-001

Rat whole-body wood smoke exposure

A total of 40 g of China fir sawdust was smouldered and the smoke channeled through a piston pump into the exposure room. Rats exposed 1 h four times per day, five days per week, for three months. Exposure-room averages: CO 90.15 ppm, O2 20.94%, PM2.5 20.4 mg/m3. Control rats breathed clean room air. Approved by the Local Ethics Committee of Guangzhou Medical University.

Equipment: Wood smoke exposure room; Piston pump; China fir sawdust

PROTOCOL:huang-wspm25-collection-001

WSPM2.5 collection and resuspension

PM2.5 collected from China fir burned in a conventional Chinese wood stove (April 23-May 6, 2015) with a high-volume sampler (TE-6070, Tisch) fitted with a PM2.5 selective-inlet head (1.13 m3/min), onto glass fibre membrane filters (1.6 um pore, 406 cm2). Filters soaked in DMSO, filtered through a 5 um needle filter, pooled; 40 mg/ml stock stored at -20 C and sonicated 3 x 25 s before use. Controls prepared from clean filters containing 0.1% DMSO.

Equipment: High-volume sampler TE-6070 (Tisch, USA) with PM2.5 selective-inlet head; Glass fibre membrane filters (1.6 um pore size); Sonicator

PROTOCOL:huang-abpas-ihc-001

AB-PAS and MUC5AC/MUC5B immunohistochemistry on rat lung

type: StainingProtocol

Right lung inflated at 25 cm H2O, fixed in 4% paraformaldehyde for 24 h, paraffin-embedded and cut into 4 um para-sagittal sections (n = 5 rats/group). Sections stained with Alcian blue/periodic acid Schiff for mucus and immunostained for MUC5AC (1:50) and MUC5B (1:200) with an immunohistochemistry detection kit (Gene Tech, Shanghai). Quantified with Image-Pro Plus 6.0.

staining type: AB-PAS fixation method: 4% paraformaldehyde detection method: DAB immunohistochemistry detection kit (Gene Tech, Shanghai)
PROTOCOL:huang-qpcr-001

Real-time quantitative RT-PCR

type: MolecularAssayProtocol

TRIzol RNA extraction; 500 ng RNA reverse transcribed in 10 ul with the PrimeScript RT Reagent Kit (Takara). 2 ul cDNA amplified in 25 ul with SYBR Premix Ex Taq on an MXP3000 QPCR system (Stratagene): 95 C 30 s; 40 cycles of 95 C 5 s and 60 C 30 s; 95 C 1 min; melt 60-95 C. Relative amounts calculated by the 2^-ddCt method.

detection method: SYBR Green real-time PCR reference gene: GAPDH normalization method: 2^-ddCt relative quantification against GAPDH platform: MXP3000 QPCR system (Stratagene, USA)
PROTOCOL:huang-elisa-muc5ac-001

MUC5AC ELISA on culture supernatants

type: MolecularAssayProtocol

50 ul of sample incubated with 50 ul bicarbonate-carbonate buffer for 2 h at 37 C, blocked with 2% BSA for 1 h, incubated with mouse anti-MUC5AC (1:200) for 2 h at 37 C, then HRP-conjugated anti-mouse IgG (1:5000) for 1 h. Developed with TMB, stopped with 2 M H2SO4, absorbance read at 450 nm. Standard curve from serially diluted bovine submaxillary gland mucin. Data expressed as the ratio of the observed value to the control group value.

detection method: colorimetric ELISA at 450 nm
PROTOCOL:huang-elisa-ligand-001

ELISA for EGFR ligands AR, TGF-alpha and HB-EGF

type: MolecularAssayProtocol

Commercial ELISA kits for AR, TGF-alpha and HB-EGF (R&D Systems) used on cell culture medium per the manufacturer's instructions; optical density measured at 450 nm.

detection method: colorimetric ELISA at 450 nm platform: R&D Systems ELISA kits
PROTOCOL:huang-wb-001

Western blot for phospho-EGFR and phospho-ERK

type: MolecularAssayProtocol

RIPA lysis with protease and phosphatase inhibitor cocktails, 30 min on ice; centrifuged 12,000 x g, 4 C, 20 min. Protein quantified by BCA. 30 ug protein per lane on 10% SDS-PAGE, transferred to PVDF, blocked in 5% milk, probed 16 h at 4 C with anti-phospho-ERK1/2 (1:1000) or anti-phospho-EGFR (1:10000), then HRP-conjugated secondary IgG and SuperSignal West Femto substrate. Membranes stripped and re-probed with anti-ERK (1:2000), anti-EGFR (1:100,000) and anti-GAPDH (1:1000) for normalization.

detection method: chemiluminescence (SuperSignal West Femto) normalization method: densitometry normalized to GAPDH or total ERK lysis buffer: RIPA buffer (Pierce) with protease and phosphatase inhibitor cocktails
PROTOCOL:huang-if-muc5ac-001

MUC5AC immunofluorescence on differentiated ALI cultures

type: StainingProtocol

Differentiated bronchial/tracheal epithelial cells fixed in 4% paraformaldehyde 20 min, permeabilized with 0.5% Triton X-100, blocked with 3% BSA 1 h, incubated overnight at 4 C with mouse monoclonal anti-MUC5AC (1:100), then Cy3-conjugated anti-mouse IgG (1:200) for 1 h; nuclei stained with DAPI 5 min. Inserts excised, mounted and imaged by confocal microscopy; MUC5AC signal expressed as the ratio of Cy3 to total DAPI fluorescence (Image-Pro Plus 6.0).

staining type: immunofluorescence fixation method: 4% paraformaldehyde counterstain: DAPI detection method: confocal fluorescence microscopy normalization method: MUC5AC (Cy3) fluorescence divided by total DAPI fluorescence